Mateon reported positive results for multiple COVID-19 drug candidates
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…
On Mar. 25, 2020, Merck announced it had donated 300,000 masks to New Jersey’s Office of Homeland Security…
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
On Mar. 24, 2020, T2 Biosystems announced it had entered into a worldwide licensing agreement for a rapid…
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
On Mar. 24, 2020, 3M and Ford Motor announced a partnership to increase the production of 3M’s powered…
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
On Mar. 24, 2020, Ology Bioservices and Inovio Pharma announced the Department of Defense (DOD) has awarded Ology…
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
On Mar. 23, 2020, the Amgen Foundation announced an initial commitment of up to $12.5 million to support…
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired…
On Mar. 23, 2020, Drug Innovation Ventures at Emory (DRIVE), and Ridgeback Biotherapeutics announced a collaboration to rapidly…
On Mar. 23, 2020, Harvard Bioscience announced that it had launched an innovative technology – known as Accumulated…
On Mar. 23, 2020, Heat Biologics announced that it was collaborating with the University of Miami to develop…
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
On Mar. 21, 2020, through its “Peace of Mind” program, Quest Diagnostics took extra measures to ensure individuals…
On Mar. 20, 2020, the U.S. Food and Drug Administration (FDA) issued a new policy that allowed manufacturers…
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…